...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: sent a e-mail to Sarah ...

see what she says & i will post it - not expecting much back & doubtful she will reply today but we will see...

 

Share
New Message
Please login to post a reply